Enlightify amends 8-K to clarify Tianping Cai's board appointment, independent director terms

Enlightify Inc.

• Appointment effective April 10, 2025, as board member, audit committee chair, and member of nominating/comp committees.
• Cai serves as Financial Director at HK Haoming International (medical device); prior risk management/audit at real estate firms.
• Independent Director Agreement signed June 5, 2025, provides $26,000 annual fee; supersedes prior Employment Agreement.
• Board determined Cai qualifies as audit committee financial expert and is independent under NYSE/SEC rules.
• Cai holds no beneficial ownership of ENFY stock and has no material interest in any transactions.